Cargando…
Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications
BACKGROUND: Healthcare access has changed drastically during the COVID-19 pandemic. Elective medical procedures, including routine office visits, were restricted raising concerns regarding opioid and benzodiazepine provider and prescription availability. OBJECTIVE: To examine how the cancelation of...
Autores principales: | Downs, Callie G., Varisco, Tyler J., Bapat, Shweta S., Shen, Chan, Thornton, J. Douglas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738763/ https://www.ncbi.nlm.nih.gov/pubmed/33317769 http://dx.doi.org/10.1016/j.sapharm.2020.06.003 |
Ejemplares similares
-
Parents’ intention to have their child vaccinated at a community pharmacy: A national cross-sectional survey
por: Varisco, Tyler J., et al.
Publicado: (2023) -
Physician perspective on the implementation of risk mitigation strategies when prescribing opioid medications: a qualitative analysis
por: Tata, Vaishnavi, et al.
Publicado: (2023) -
Intention to get naloxone among patients prescribed opioids for chronic pain
por: Huang, Yinan, et al.
Publicado: (2022) -
Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States
por: de Dios, Constanza, et al.
Publicado: (2021) -
Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses
por: Zin, Che Suraya, et al.
Publicado: (2017)